Neurological manifestations and complications of COVID-19. A literature review
DOI:
https://doi.org/10.12775/JEHS.2021.11.08.039Keywords
COVID-19, SARS-CoV-2 infection, neurological complications, neurological manifestations, neuroinvasion, neurovirulenceAbstract
Introduction. The first case of SARS-CoV-2 infection was identified in December 2019 in Wuhan, China. The disease spread rapidly worldwide and the WHO declared a pandemic on March 11, 2020. Although coronavirus disease 2019 (COVID-19) has been associated primarily with respiratory disorders, more and more research is focusing on neurological manifestations and complications.
Objective. The aim of the review is to systematize and update the knowledge and available research on neurological complications among COVID-19 patients.
Review methods. A systematic search of PubMed and Google Scholar databases was conducted for studies. The following keywords combinations were used: COVID-19, SARS-CoV-2 infection, neurological complications, neurological manifestations, neuroinvasion, neurovirulence.
Results. The disease in most patients is characterized by mild to medium fever, fatigue, dry cough, dyspnea, muscle pain and headache. ACE2, which is the receptor for SARS-COV-2, is ubiquitously expressed in a variety of human organs, including the brain. Following previous reports, these receptors are expressed in both glial cells and neurons. Many studies have reported neurological symptoms and complications among COVID-19 patients. The reported manifestations include: smell and taste disturbance, non-specific symptoms such as myalgia, headache and dizziness, acute cerebrovascular complications, encephalopathy, meningoencephalitis/encephalitis, seizure and complications of the peripheral nervous system.
Conclusion. Healthcare professionals dealing with COVID-19, neuroscientists, and the general public should be aware of the neurological complications of COVID-19. Further studies are needed to assess the incidence of COVID-19 neurological complications in different populations and more analyzes are also required to understand the detailed mechanism of how the virus affects the nervous system.
References
Drexler J, Gloza-Rausch F, Glende J et al. Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences, J Virol. 2010 Nov;84(21):11336-49.
Wilde A, Snijder E, Kikkert M, Hemert M, Host Factors in Coronavirus Replication, Curr Top Microbiol Immunol. 2018;419:1-42.
Zhu N, Zhang D, Wang W et al., A Novel Coronavirus from Patients with Pneumonia in China, 2019, N Engl J Med. 2020 Feb 20;382(8):727-733.
"WHO Director-General's opening remarks at the media briefing on COVID-19 – 11 March 2020". World Health Organization (WHO).
Wang D, Hu B, Hu Ch et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China, JAMA. 2020 Mar 17;323(11):1061-1069.
Chen N, Zhou M, Dong X et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet. 2020 Feb 15;395(10223):507-513.
Thevarajan I, Buising K, Cowie B, Clinical presentation and management of COVID-19, Med J Aust. 2020 Aug;213(3):134-139.
Pantelis Ch, Jayaram M, Hannan A et al. Neurological, neuropsychiatric and neurodevelopmental complications of COVID-19, Aust N Z J Psychiatry. 2020 Oct 1;4867420961472.
Wu Ch, Chen X, Cai Y et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China, JAMA Intern Med. 2020 Jul 1;180(7):934-943.
Roy D, Ghosh R, Dubey S et al. Neurological and Neuropsychiatric Impacts of COVID-19 Pandemic, Can J Neurol Sci. 2021 Jan;48(1):9-24.
Li Y, Bai W, Hashikawa T, The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients, J Med Virol. 2020 Jun;92(6):552-555.
Tsai L, Hsieh S, Chang Y, Neurological manifestations in severe acute respiratory syndrome, Acta Neurol Taiwan. 2005 Sep;14(3):113-9.
Kim J, Heo J, Kim H et al. Neurological Complications during Treatment of Middle East Respiratory Syndrome, J Clin Neurol. 2017 Jul;13(3):227-233.
Bodnar B, Patel K, Ho W et al. Cellular mechanisms underlying neurological/neuropsychiatric manifestations of COVID-19, J Med Virol. 2021 Apr;93(4):1983-1998.
Cebrián J, Gonzalez-Martinez A, García-Blanco M et al. Headache and impaired consciousness level associated with SARS-CoV-2 in CSF: A case report, Neurology. 2020 Aug 11;95(6):266-268.
Virhammar J, Kumlien E, Fällmar D et al. Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid, Neurology. 2020 Sep 8;95(10):445-449.
Andriuta D, Roger P, Thibault W et al. COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF, J Neurol. 2020 Oct;267(10):2810-2811.
Solomon I, Normandin E, Bhattacharyya S et al. Neuropathological Features of Covid-19, N Engl J Med. 2020 Sep 3;383(10):989-992.
Hoffmann M, Kleine-Weber H, Schroeder S et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell. 2020 Apr 16;181(2):271-280.e8.
Choi J, Lee H, Park J et al. Altered COVID-19 receptor ACE2 expression in a higher risk group for cerebrovascular disease and ischemic stroke, Biochem Biophys Res Commun. 2020 Jul 30;528(3):413-419.
Baig A, Khaleeq A, Ali U, Syeda H, Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms, ACS Chem Neurosci. 2020 Apr 1;11(7):995-998.
Chen X, Laurent S, Onur O et al. A systematic review of neurological symptoms and complications of COVID-19, J Neurol. 2021 Feb;268(2):392-402.
Chen R, Wang K, Yu J et al. The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains, Front Neurol. 2021 Jan 20;11:573095.
Butowt R, Bilinska K, SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection, ACS Chem Neurosci. 2020 May 6;11(9):1200-1203.
Alam S, Willows S, Kulka M, Sandhu J, Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system, Eur J Neurol. 2020 Nov;27(11):2348-2360.
Chigr F, Merzouki M, Najimi M, Comment on "The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients", J Med Virol. 2020 Jul;92(7):703-704.
Mao L, Jin H, Wang M et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China, JAMA Neurol. 2020 Jun 1;77(6):683-690.
Lechien J, Chiesa-Estomba C, Siati D et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study, Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261.
Speth M, Singer-Cornelius T, Oberle M et al. Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics, Otolaryngol Head Neck Surg. 2020 Jul;163(1):114-120.
Kaye R, Chang D, Kazahaya K et al. COVID-19 Anosmia Reporting Tool: Initial Findings, Otolaryngol Head Neck Surg. 2020 Jul;163(1):132-134.
Favas T, Dev P, Chaurasia R et al. Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions, Neurol Sci. 2020 Dec;41(12):3437-3470.
Lechien J, Chiesa-Estomba C, Place S et al. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019, J Intern Med. 2020 Sep;288(3):335-344.
Karadaş Ö, Öztürk B, Sonkaya A et al. A prospective clinical study of detailed neurological manifestations in patients with COVID-19, Neurol Sci. 2020 Aug;41(8):1991-1995.
Helms J, Kremer S, Merdji H et al. Neurologic Features in Severe SARS-CoV-2 Infection, N Engl J Med. 2020 Jun 4;382(23):2268-2270.
Li Y, Li M, Wang M et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study, Stroke Vasc Neurol. 2020 Sep;5(3):279-284.
Jasti M, Nalleballe K, Dandu V, Onteddu S, A review of pathophysiology and neuropsychiatric manifestations of COVID-19, J Neurol. 2021 Jun;268(6):2007-2012.
Moriguchi T, Harii N, Goto J et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2, Int J Infect Dis. 2020 May;94:55-58.
Zoghi A, Ramezani M, Roozbeh M et al. A case of possible atypical demyelinating event of the central nervous system following COVID-19, Mult Scler Relat Disord. 2020 Sep;44:102324.
Duong L, Xu P, Liu A, Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in Downtown Los Angeles, early April 2020, Brain Behav Immun. 2020 Jul;87:33.
Scullen T, Keen J, Mathkour M et al. Coronavirus 2019 (COVID-19)-Associated Encephalopathies and Cerebrovascular Disease: The New Orleans Experience, World Neurosurg. 2020 Sep;141:e437-e446.
Farhadian S, Glick L, Vogels Ch et al. Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19, BMC Neurol. 2020 Jun 18;20(1):248.
Libbey J, Kennett N, Wilcox K et al. Interleukin-6, produced by resident cells of the central nervous system and infiltrating cells, contributes to the development of seizures following viral infection, J Virol. 2011 Jul;85(14):6913-22.
Homma Y, Watanabe M, Inoue K, Moritaka T, Coronavirus Disease-19 Pneumonia with Facial Nerve Palsy and Olfactory Disturbance, Intern Med. 2020;59(14):1773-1775.
Abdelnour L, Abdalla M, Babiker S, COVID 19 infection presenting as motor peripheral neuropathy, J Formos Med Assoc. 2020 Jun;119(6):1119-1120.
Toscano G, Palmerini F, Ravaglia S et al. Guillain-Barré Syndrome Associated with SARS-CoV-2, N Engl J Med. 2020 Jun 25;382(26):2574-2576.
Hasan I, Saif-Ur-Rahman K, Hayat S et al. Guillain-Barré syndrome associated with SARS-CoV-2 infection: A systematic review and individual participant data meta-analysis, J Peripher Nerv Syst. 2020 Dec;25(4):335-343.
Reyes-Bueno J, García-Trujillo L, Urbaneja P et al. Miller-Fisher syndrome after SARS-CoV-2 infection, Eur J Neurol. 2020 Sep;27(9):1759-1761.
Manganotti P, Pesavento V, Stella A et al. Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2, J Neurovirol. 2020 Aug;26(4):605-606.
Gutiérrez-Ortiz C, Méndez-Guerrero A, Rodrigo-Rey S et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19, Neurology. 2020 Aug 4;95(5):e601-e605.
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 808
Number of citations: 0
